Oct 1 |
Even after rising 11% this past week, Evotec (ETR:EVT) shareholders are still down 84% over the past three years
|
Sep 26 |
Novo Nordisk And Evotec Collaborate On Stem Cell-Based Therapy Development
|
Sep 26 |
Evotec, Novo Nordisk form technology development partnership for stem cell-based therapies
|
Sep 26 |
Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-Generation Cell Therapies
|
Sep 23 |
Evotec opens first European biologics facility in France
|
Sep 20 |
Just - Evotec Biologics Opens Cutting-Edge Biologics Facility - J.POD(R) Toulouse, France (EU)
|
Sep 6 |
Evotec partners X-Chem for tech-enabled drug discovery
|
Sep 5 |
Evotec and X-Chem Collaborate to Accelerate Early-Stage Drug Discovery
|
Sep 3 |
Evotec Announces Change in Management Board
|
Aug 30 |
Evotec: Weak Performance, But Long-Term Potential Is There
|